Publications by authors named "Nick Devoogdt"

Claim this Profile
I
Immune modulation following α and β radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model.
Hannelore Ceuppens, Kirsten De Ridder, Thomas Ertveldt, Katty Zeven, Wout De Mey, Nick Devoogdt

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.
Sana M Arnouk, Daliya Kancheva, Helena Van Damme, Guillaume E Courtoy, Romina Mora Barthelmess, Nick Devoogdt

Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VyPAL2 peptide asparaginyl ligase enables versatile workflows for radiolabeling single-domain antibody-based theranostics.
Sofie Declercq, Wei Min Chen, Abbas El Sahili, Arthur Lamouroux, Ilyana Gonzales, Nick Devoogdt

J Control Release· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumors.
Fien Meeus, Arne Van der Vreken, Dorien Autaers, Timo W M De Groof, Arthur Esprit, Nick Devoogdt

Mol Ther Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical synergistic effects when combining a radiolabelled HER2-targeting single domain antibody with PARP inhibitor Olaparib.
Jonatan Dewulf, Laurent Navarro, Nina Dumauthioz, Marion Berdal, Surasa Nagachinta, Nick Devoogdt

J Transl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanobody-based Pannexin1 channel inhibitors increase survival after cardiac ischemia/reperfusion.
Olga M Rusiecka, Filippo Molica, Linda Clochard, Raf Van Campenhout, Timo W M De Groof, Nick Devoogdt

Cell Tissue Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Preclinical Validation of an Anti-B7-H3-Specific Radiotracer: A Non-Invasive Imaging Tool to Guide B7-H3-Targeted Therapies.
Cyprine Neba Funeh, Fien Meeus, Niels Van Winnendael, Timo W M De Groof, Matthias D'Huyvetter, Nick Devoogdt

Pharmaceuticals (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing antibody PET imaging: a comparative preclinical analysis of nanobody and minibody-like PET tracers.
Katty Zeven, Herlinde Dierick, Matthijs Sevenois, Henri Baudhuin, Laurent Navarro, Nick Devoogdt

Eur J Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VSIG4-Expressing Macrophages Contribute to Antiparasitic and Antimetastatic Responses in the Peritoneal Cavity.
Els Lebegge, Daliya Kancheva, Jolien Van Craenenbroeck, Sam Ernst, Pauline M R Bardet, Nick Devoogdt

Eur J Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient α and β radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model.
Hannelore Ceuppens, Ana Rita Pombo Antunes, Laurent Navarro, Thomas Ertveldt, Marion Berdal, Nick Devoogdt

Eur J Nucl Med Mol Imaging· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β.
Timo W M De Groof, Yoline Lauwers, Tessa De Pauw, Mohit Saxena, Cécile Vincke, Nick Devoogdt

Eur J Nucl Med Mol Imaging· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of tumor-associated macrophage dynamics during immunotherapy using a CD163-specific nanobody-based immunotracer.
Yoline Lauwers, Timo W M De Groof, Cécile Vincke, Jolien Van Craenenbroeck, Neema Ahishakiye Jumapili, Nick Devoogdt

Proc Natl Acad Sci U S A· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy.
Jonatan Dewulf, Sam Massa, Laurent Navarro, Yana Dekempeneer, Francis Santens, Nick Devoogdt

J Nanobiotechnology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity.
Fien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad, Katty Zeven, Dorien Autaers, Nick Devoogdt

J Immunother Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies.
Niels Vandewalle, Nathan De Beule, Ann De Becker, Elke De Bruyne, Eline Menu, Nick Devoogdt

Exp Hematol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and Characterization of Novel Pan-Cancer Anti-uPAR Fluorescent Nanobodies as Tools for Image-Guided Surgery.
Łukasz Mateusiak, Sam Floru, Timo W M De Groof, Janne Wouters, Noemi B Declerck, Nick Devoogdt

Adv Sci (Weinh)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancements in nuclear imaging using radiolabeled nanobody tracers to support cancer immunotherapy.
Katty Zeven, Yoline Lauwers, Lynn De Mey, Jens M Debacker, Tessa De Pauw, Nick Devoogdt

Immunother Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generic semi-automated radiofluorination strategy for single domain antibodies: [F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer.
Herlinde Dierick, Laurent Navarro, Hannelore Ceuppens, Thomas Ertveldt, Ana Rita Pombo Antunes, Nick Devoogdt

EJNMMI Radiopharm Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization.
Heleen Hanssens, Fien Meeus, Yannick De Vlaeminck, Quentin Lecocq, Janik Puttemans, Nick Devoogdt

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia.
Niels Vandewalle, Hatice Satilmis, Emma Verheye, Rong Fan, Yanmeng Wang, Nick Devoogdt

Theranostics· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties.
Heleen Hanssens, Fien Meeus, Emma L Gesquiere, Janik Puttemans, Yannick De Vlaeminck, Nick Devoogdt

Int J Mol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels.
Julie Heremans, Robin Maximilian Awad, Jessica Bridoux, Thomas Ertveldt, Vicky Caveliers, Nick Devoogdt

Eur J Pharm Biopharm· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial Assessing the Repeatability and Tumor Uptake of [Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma.
Odrade Gondry, Vicky Caveliers, Catarina Xavier, Laurens Raes, Marian Vanhoeij, Nick Devoogdt

J Nucl Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management.
Ying Cong, Nick Devoogdt, Philippe Lambin, Ludwig J Dubois, Ala Yaromina

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α.
Yana Dekempeneer, Sam Massa, Francis Santens, Laurent Navarro, Marion Berdal, Nick Devoogdt

J Nucl Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis